Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown125%
recruiting125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Menstrual Cycle Symptoms and Female Health

NCT07699224
completednot_applicable

PROJECT 2 EXAMPLE: Feedback X Prevalence Using Dermatology Stimuli

NCT05244122
unknown

Prevalence of Bronchiectasis in COPD Patients

NCT04101448
completednot_applicable

Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms

NCT00844974

Clinical Trials (4)

Showing 4 of 4 trials
NCT07699224

Menstrual Cycle Symptoms and Female Health

Recruiting
NCT05244122Not Applicable

PROJECT 2 EXAMPLE: Feedback X Prevalence Using Dermatology Stimuli

Completed
NCT04101448

Prevalence of Bronchiectasis in COPD Patients

Unknown
NCT00844974Not Applicable

Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4